期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Non Hodgkin’s Lymphoma with Right Atrial Intra Cardiac Metastases
1
作者 Gaind Saurabh Nitin Kumar Kashyap +5 位作者 Mehsare Pranay Suresh Niraghatam Harshavardhan Nirupam Sekhar Chakraborty Rahul Satarkar Mudalsha Ravina Shiva Thakur 《World Journal of Cardiovascular Surgery》 2023年第7期120-127,共8页
Background: Diffuse Large B-Cell Lymphoma (DLBCL) is the most variant of Non-Hodgkin’s Lymphoma (NHL) and also the most common variant with secondary intracardiac masses. Case summary: 7 years old child presented to ... Background: Diffuse Large B-Cell Lymphoma (DLBCL) is the most variant of Non-Hodgkin’s Lymphoma (NHL) and also the most common variant with secondary intracardiac masses. Case summary: 7 years old child presented to emergency with acute decompensated cardiac failure, ascites and tender hepatomegaly. 2D echo evaluation was suggestive of large intracardiac mass in the right atrium almost completely obstructing Tricuspid valve orifice, gross pericardial effusion and dilated Inferior Vena Cava (IVC). Emergency tumor excision surgery was performed which revealed 4 × 4 cm pinkish firm mass arising from anterior Tricuspid annulus which was completely excised. Child was extubated on postoperative day (POD) 0 and was on minimal inotropic support. Ascites reduced significantly on POD1 allowing abdominal palpation which revealed a mass in the epigastric region. This prompted evaluation by pediatrician and oncology workup suggestive of increased 18-Flouro Deoxy Glucose (18-FDG) uptake in the mediastinum, abdomen, bilateral proximal thighs, all mediastinal lymph nodal stations, bilateral lung hilar stations 10R, 10L involving all encasing the heart and great vessels with pleural deposits, Celiac trunk, superior Mesenteric Artery (SMA), Portal vein, IVC and abdominal aorta. Histo pathology Examination (HPE) and Immuno Histo Chemistry (IHC) of intracardiac mass revealed DLBCL which is metastatic in nature. Chemotherapy was started as per (French American British Lymphomes Malins B) FAB LMB-96 protocol with the child currently in the Induction phase having poor prognosis and less survival interval. Conclusion: Surgery can be considered a treatment option for metastatic intracardiac masses during emergency scenarios like cardiogenic shock to relieve obstruction along the pathway of blood flow in the heart even though we may not be able to completely excise the tumor surgically. 展开更多
关键词 Diffuse Large B-Cell lymphoma (DLBCL) non-hodgkins lymphoma (NHL) secondary Intracardiac metastasis Cardiogenic shock Immuno Histo Chemistry (IHC)
下载PDF
Primary hepatic peripheral T-cell lymphoma associated with Epstein-Barr viral infection
2
作者 Daryl Ramai Emmanuel Ofori +1 位作者 Sofia Nigar Madhavi Reddy 《World Journal of Hepatology》 CAS 2018年第2期347-351,共5页
Primary hepatic peripheral T-cell lymphoma(H-PTCL) is one of the rarest forms of non-Hodgkin lymphoma. We report a patient who presented with worsening jaundice, abdominal pain, and vomiting. Laboratory values were si... Primary hepatic peripheral T-cell lymphoma(H-PTCL) is one of the rarest forms of non-Hodgkin lymphoma. We report a patient who presented with worsening jaundice, abdominal pain, and vomiting. Laboratory values were significant for elevated total bilirubin, alkaline phosphatase, and liver aminotransferases. Following a liver biopsy, histopathology revealed several large dense clusters of atypical T-lymphocytes which were CD2+, CD3+, CD5+, CD7-, CD4+, CD8-, CD56-, CD57-, CD30+ by immunohistochemistry. The proliferation index was approximately 70% by labeling for ki67/mib1. The above histological profile was consistent with peripheral T-cell lymphoma of the liver. Epstein-Barr viral serology indicated a remote infection, a likely risk factor for PTCL. Bone marrow biopsy was negative for malignancy, further supporting hepatic origin. 展开更多
关键词 PRIMARY lymphoma liver cancer non-hodgkins lymphoma T-CELL lymphoma
下载PDF
癌性抑制因子在非霍奇金淋巴瘤肝转移组织中的表达及其临床意义 被引量:1
3
作者 陈昌海 《检验医学与临床》 CAS 2016年第3期307-308,311,共3页
目的探讨癌性抑制因子(CIP2A)在非霍奇金淋巴瘤肝转移组织中表达的临床意义。方法选取该院2005年6月至2014年9月38例非霍奇金淋巴瘤肝转移患者,应用RT-PCR法检测非霍奇金淋巴瘤肝转移、肝转移灶周边组织及正常肝组织的CIP2A含量,并分析... 目的探讨癌性抑制因子(CIP2A)在非霍奇金淋巴瘤肝转移组织中表达的临床意义。方法选取该院2005年6月至2014年9月38例非霍奇金淋巴瘤肝转移患者,应用RT-PCR法检测非霍奇金淋巴瘤肝转移、肝转移灶周边组织及正常肝组织的CIP2A含量,并分析其与肿瘤病理特征之间的关系。结果 38例患者中,非霍奇金淋巴瘤肝转移组织CIP2A表达阳性26例,阳性率68.4%,肝转移灶周边组织表达阳性9例,阳性率23.68%,正常组织未见CIP2A表达,CIP2A含量与肝转移瘤直径、乳酸脱氢酶(LDH)水平及肿瘤个数具有密切的相关性。结论 CIP2A在非霍奇金淋巴瘤肝转移组织中高表达,有特异性,与其病理特征呈相关关系,可作为非霍奇金淋巴瘤肝转移诊断与治疗的分子标志物。 展开更多
关键词 非霍奇金淋巴瘤肝转移 癌性抑制因子 免疫组织化学
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部